Catalyst Wire Dossier Catalyst Wire Dossier

First biological drug (unnamed)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for First biological drug (unnamed), covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug [Phase 4]

See pricing